Wedbush Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $26

Moomoo News12:31 ET · Ratings

Wedbush Lifts Price Target on Travere Therapeutics to $26 From $25, Keeps Outperform Rating

MT NewswiresJan 23 08:01 ET · Ratings

Evercore Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Maintains Target Price $33

Moomoo NewsJan 16 00:32 ET · Ratings

Travere Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow JonesJan 15 07:08 ET · Ratings

Travere Therapeutics Analyst Ratings

BenzingaJan 15 06:56 ET · Ratings

H.C. Wainwright Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $22

Moomoo NewsJan 15 06:33 ET · Ratings